ctrl K

AI Score

Unlock

SAB Biotherapeutics Inc. (SABS)

AI Score

Unlock

1.56

-0.15 (-8.77%)

At close: Mar 03, 2025, 3:59 PM

1.56

-0.32%

After-hours: Mar 03, 2025, 04:00 PM EST

SAB Biotherapeutics Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Cash & Equivalents	56.57M	15.05M	33.21M	12.61M	6.35M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	350.23K	467.69K	n/a	n/a	n/a
Receivables	n/a	5.56M	8.01M	20.57M	2.82M
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.34M	1.49M	8.97M	1.28M	124K
Total Current Assets	58.91M	22.1M	48.42M	34.46M	9.29M
Property-Plant & Equipment	24.68M	28.34M	30.95M	22.08M	8.71M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	25.03M	28.81M	30.95M	22.08M	8.71M
Total Assets	83.94M	50.9M	79.37M	56.54M	18M
Account Payables	945.93K	3.68M	4.46M	7.38M	2.17M
Deferred Revenue	1.32M	n/a	100K	100K	n/a
Short-Term Debt	1.85M	2.02M	3.1M	1.66M	1.95M
Other Current Liabilities	6.65M	9.24M	16.81M	1.92M	-4.12M
Total Current Liabilities	10.81M	14.99M	24.68M	11.06M	4.62M
Long-Term Debt	4.05M	4.53M	5.42M	6.47M	53.45K
Other Long-Term Liabilities	11.77M	320.93K	10.72M	n/a	15.64M
Total Long-Term Liabilities	15.83M	4.85M	16.14M	6.47M	15.69M
Total Liabilities	26.64M	19.85M	40.82M	17.53M	20.31M
Total Debt	5.91M	5.93M	6.74M	8.13M	7.64M
Common Stock	929.00	5.09K	4.35K	3.52K	3.52K
Retained Earnings	-90.06M	-47.87M	-29.13M	-11.98M	-32.1M
Comprehensive Income	26.42K	n/a	n/a	n/a	n/a
Shareholders Equity	57.3M	31.06M	38.55M	39.01M	-2.31M
Total Investments	n/a	n/a	n/a	n/a	n/a